2018

Lopez-Alvarez VM, Puigdomenech M, Navarro X, Cobianchi S.
Monoaminergic descending pathways contribute to modulation of neuropathic pain by increasing-intensity treadmill exercise after peripheral nerve injury.
Exp Neurol 2018, 299:42-55. IF: 4,562.

Gonzalez-Perez F, Hernández J, Heimann C, Phillips JB, Udina E, Navarro X.
Schwann cells and mesenchymal stem cells in laminin or fibronectin aligned matrices support regeneration across a critical size defect of 15 mm in the rat sciatic nerve.
J Neurosurg Spine 2018, 28:109-118. IF: 2,998.

Mòdol-Caballero G, Santos D, Navarro X, Herrando-Grabulosa M.
Neuregulin 1 reduces motoneuron cell death and promotes neurite growth in an in vitro model of motoneuron degeneration.
Front Cell Neurosci 2018, 11:431. IF: 3,900.

Sánchez-Brualla I, Boulenguez P, Brocard C, Liabeuf S, Viallat-Lieutaud A, Navarro X, Udina E, Brocard F.
Activation of 5-HT2A receptors restores KCC2 function and reduces neuropathic pain after spinal cord injury.
Neuroscience 2018, 387:48-57. IF: 3,244.

De la Oliva N, Navarro X, Del Valle J.
Time course study of long-term biocompatibility and foreign body reaction to intraneural polyimide-based implants.
J Biomed Materials Res: Part A 2018, 106:746-757. IF: 3,221.

Del Valle J, Santos D, Delgado-Martínez I, de la Oliva N, Giudetti G, Micera S, Navarro X.
Segregation of motor and sensory axons regenerating through bicompartmental tubes by combining extracellular matrix components with neurotrophic factors.
J Tissue Eng Regen Med 2018, 12(4):e1991-e2000. IF: 3,319.

Romeo-Guitart D, Forés J, Herrando-Grabulosa M, Valls R, Leiva-Rodríguez T, Galea E, González-Pérez F, Navarro X, Petegnief V, Bosch A, Coma M, Mas JM, Casas C.
Neuroprotective drug for nerve trauma revealed using artificial intelligence.
Sci Rep 2018, 8(1):1879. IF: 4,011.

Rando A, Pastor D, Viso-León MC, Martínez A, Manzano R, Navarro X, Osta R, Martínez S.
Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1(G93A) mice and modulates expression of prognosis biomarkers of the disease.
Stem Cell Res Ther 2018; 9(1):90. IF: 4,627.

De la Oliva N, Mueller M, Stieglitz T, Navarro X, del Valle J.
On the use of Parylene C polymer as substrate for peripheral nerve electrodes.
Sci Rep 2018, 8(1):5965. IF: 4,011

Simó M, Navarro X, Yuste VJ, Bruna J.
Autonomic nervous system and cancer.
Clin Auton Res 2018, 28(3):301-314. IF: 2,485.

Cerveró C, Blasco A, Tarabal O, Casanovas A, Piedrafita L, Navarro X, Esquerda JE, Calderó J.
The sigma-1 receptor agonist PRE-084 prevents reactive gliosis and central synapse loss but not motoneuron death in the Smn2B/- mouse model of spinal muscular atrophy.
J Neuropathol Exp Neurol 2018, 77:577-597. IF: 3,460.

Romeo-Guitart D, Leiva-Rodríguez T, Espinosa-Alcantud M, Sima N, Vaquero A, Domínguez-Martín H, Ruano D, Casas C.
SIRT1 activation with neuroheal is neuroprotective but SIRT2 inhibition with AK7 is detrimental for disconnected motoneurons.
Cell Death Dis 2018; 9(5):531. IF: 5,959.

Leiva-Rodríguez T, Romeo-Guitart D, Marmolejo-Martínez-Artesero S, Herrando-Grabulosa M, Bosch A, Forés J, Casas C.
ATG5 overexpression is neuroprotective and attenuates cytoskeletal and vesicle-trafficking alterations in axotomized motoneurons.
Cell Death Dis 2018; 9(6):626. IF: 5,959.

Penas C, Navarro X.
Epigenetic modifications of neuroinflammatory mediators and neuronal hyperexcitability associated to neuropathic pain after trauma.
Front Cell Neurosci 2018, 12:158. IF: 3,900.

Lago N, Pannunzio B, Amo-Aparicio J, López-Vales R, Peluffo H.
CD200 modulates spinal cord injury neuroinflammation and outcome through CD200R1.
Brain Behav Immun 2018, 73:416-426. IF: 6,170.

David S, Kroner A, Greenhalgh A, Zarruk JG, López-Vales R.
Myeloid cell responses after spinal cord injury.
J Neuroimmunol 2018, 321:97-108. IF: 2,832.

Piñol-Jurado P, Suárez-Calvet X, Fernández-Simón E, Gallardo E, de la Oliva N, Martínez-Muriana A, Gómez-Gálvez P, Escudero LM, Pérez-Peiró M, Wollin L, de Luna N, Navarro X, Illa I, Díaz-Manera J.
Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy.
Cell Death Dis 2018; 9(7):776. IF: 5,959.

Amo-Aparicio J, Martinez-Muriana A, Sanchez-Fernandez A, Lopez-Vales R.
Neuroinflammation quantification for spinal cord injury
Curr Protoc Immunol 2018, 123:e57. IF: 1,558.

Xue N, Delgado-Martinez I, Sun J, Cheng Y, Liu C.
Flexible multichannel vagus nerve electrode for stimulation and recording for heart failure treatment
Biosens Bioelectron 2018, 112:114-119. IF: 9,518.

Navarro X, Geuna S, Grothe C, Haastert-Talini K.
Introduction: Thematic Papers Issue on Peripheral Nerve Regeneration and Repair.
Anat Rec (Hoboken) 2018, 301:1614-1617. IF: 1,329.

Sanchez-Brualla I, Calls-Cobos A, Udina E.
Minocycline does not reduce the regenerative capacity of peripheral motor and sensory neurons after a conditioning injury in mice
Anat Rec (Hoboken) 2018; 301(10):1638-1645. IF: 1,329.

De la Oliva N, Navarro X, Del Valle J.
Dexamethasone reduces the foreign body  reaction to intraneural electrode implants in the peripheral nerve of the rat.
Anat Rec (Hoboken) 2018; 301:1722-1733. IF: 1,329.

Besora S, Santos C, Izquierdo C, Martinez-Villacampa MM, Bruna J, Velasco R.
Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients.
J Cancer Res Clin Oncol 2018; 144(9):1793-1801. IF: 3,332.

Cayuela N, Simó M, Majós C, Rifà-Ros X, Gállego Pérez-Larraya J, Ripollés P, Vidal N, Miró J, Gil F, Gil-Gil M, Plans G, Graus F, Bruna J.
Seizure-susceptible brain regions in glioblastoma: identification of patients at risk.
Eur J Neurology 2018, 25(2):387-394. IF: 4,387.

Bruna J, Velasco R.
Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy.
Neural Regen Res 2018, 13(5):775-778. IF: 2,472.

Alé A, Argyriou AA, Bruna J.
Sphingolipid metabolism products: potential new players in the pathogenesis of bortezomib-induced neuropathic pain
Ann Transl Med 2018, 6(Suppl 1):S78. IF: 3,689.

Cortes M, Garcia-Alias G, Tansey KE.
A "Snapshot" of the advances in SCI. Editorial in the special issue "Spinal Cord Injury Therapeutics”.
Neurotherapeutics 2018; 15:527-528. IF: 5,552.